Researchers introduced a metasurface-based optical learning machine (MOLM) that achieves scalable, high-performance AI for imaging tasks including radiology and pathology.
Key Details
- 1The MOLM integrates 41 million optical parameters using a silicon metasurface, enabling ultra-wide optical neural networks.
- 2Performance matches state-of-the-art digital models on challenging computer vision tasks, including MNIST (99.2% accuracy), CIFAR-10 (91.6%), and medical imaging such as chest x-ray and cancer WSI analysis.
- 3In cancer whole-slide imaging, MOLM achieved results comparable to SAM (a top segmentation model), but in just 1.02 seconds versus 1.48 hours for SAM.
- 4The same device handled six different tasks (classification, segmentation, action recognition) without reconfiguration, showing broad versatility.
- 5System is highly robust to fabrication errors (±6% variation causing <1% accuracy drop), and works with incoherent illumination (over 98.3% accuracy across spectral bandwidths).
- 6In a clinical context, MOLM could process over 42,000 whole-slide pathology cases per day, versus only 8 for SAM, highlighting real-world impact.
Why It Matters
The MOLM’s drastic improvement in speed, robustness, and parameter scalability could fundamentally change how radiologists and pathologists use AI in practice, allowing analysis of massive datasets in real time with minimal hardware costs. This technology may enable wider adoption of AI in resource-limited healthcare settings and paves the way for next-generation imaging AI workflows.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.